Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

2.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

3.

Squeezing through tiny blood vessels may trigger melanoma cells to spread

4.

Fear of hair loss might cause some to reject cancer treatment

5.

Q&A: Why adolescents and young adults with cancer are falling behind


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot